Last reviewed · How we verify
NCT05604378
Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis
trial testing Gastrectomy in Gastric Cancer in 460 participants. Completed in 28 October 2022.
28 October 2022
Quick facts
| Lead sponsor | Saint Vincent's Hospital, Korea |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 460 |
| Start date | 3 August 2022 |
| Primary completion | 28 October 2022 |
| Estimated completion | 28 October 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Gastrectomy
Conditions studied
- Gastric Cancer — all drugs for Gastric Cancer →
- EBV Infection — all drugs for EBV Infection →
- MSI — all drugs for MSI →
Sponsor
Saint Vincent's Hospital, Korea
Who can join
Eligibility, any sex, with Gastric Cancer or EBV Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The data of 460 gastric cancer patients who underwent curative gastrectomy with D2 lymph node dissection between January 2017 and February 2022 were analyzed. The clinicopathological features and prognosis of the patients with EBV-positive gastric cancers were compared with those of EBV-negative gastric cancers. Immunohistochemistry for epidermal growth factor receptor (EGFR), C-erb B2, Ki-67, and p53 was performed. Additionally, in situ hybridization was conducted to detect EBV, and microsatellite instability (MSI) analysis was used to assess the deficiency in mismatch repair (MMR) genes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05604378
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gastrectomy
Trials testing the same drug.
- NCT05038098 — Magnetic Sentinel Lymph Node Mapping in Gastric Cancer · Phase 1 · not yet recruiting
- NCT06798376 — Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer · recruiting
- NCT05180864 — Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer · NA · recruiting
- NCT05800236 — Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine · NA · unknown
- NCT05753306 — Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Periton · Phase 2 · recruiting
Other recruiting trials for Gastric Cancer
Currently open trials in the same condition.
- NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
- NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
- NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting
Other Saint Vincent's Hospital, Korea trials
Trials by the same sponsor.
- NCT07045623 — Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients · NA · recruiting
- NCT06756828 — Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spec · NA · not yet recruiting
- NCT06477562 — Surveillance Endoscopy After Proximal Gastriectomy With Double Tract Reconstruction. · completed
- NCT06186037 — Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy i · Phase 4 · recruiting
- NCT05971225 — Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05604378 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saint Vincent's Hospital, Korea
- Last refreshed: 3 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604378.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing